Editas Medicine
EDIT
#8291
Rank
โ‚ฌ0.20 B
Marketcap
2,08ย โ‚ฌ
Share price
-0.41%
Change (1 day)
2.62%
Change (1 year)

Revenue for Editas Medicine (EDIT)

Revenue in 2025 (TTM): โ‚ฌ43.17 Million

According to Editas Medicine 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ39.83 Million. In 2024 the company made a revenue of โ‚ฌ31.05 Million a decrease over the revenue in the year 2023 that were of โ‚ฌ70.67 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Editas Medicine from 2015 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ43.17 M39.05%
2024 โ‚ฌ31.05 M-56.06%
2023 โ‚ฌ70.67 M284.59%
2022 โ‚ฌ18.37 M-18.53%
2021 โ‚ฌ22.55 M-69.42%
2020 โ‚ฌ73.76 M302.49%
2019 โ‚ฌ18.32 M-34.35%
2018 โ‚ฌ27.91 M144%
2017 โ‚ฌ11.44 M98.82%
2016 โ‚ฌ5.75 M286.25%
2015 โ‚ฌ1.48 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novocure
NVCR
โ‚ฌ0.55 B 1,284.71% Jersey
Novavax
NVAX
โ‚ฌ0.87 B 2,108.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
โ‚ฌ0.12 M-99.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
โ‚ฌ18.75 M-52.92%๐Ÿ‡ฌ๐Ÿ‡ง UK